A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) can help curb alcohol cravings. But the limitations of the study, such as ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
The study reports that people are finding drugs like Ozempic and Wegovy helpful to manage cravings, not just for food, but ...
Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results